Aurora kinase inhibitor SCH-1473759, Purity ≥98%

Synonym: 1094069-99-4; SCH-1473759; 2-(Ethyl((5-((6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl)amino)isothiazol-3-yl)methyl)amino)-2-methylpropan-1-ol; SCH 1473759; CHEMBL1232515; 2-{Ethyl[(5-{[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino}isothiazol-3-yl)methyl]amino}-2-methylpropan-1-ol; 2-{Ethyl[(5-{[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino}-1,2-thiazol-3-yl)methyl]amino}-2-methylpropan-1-ol; Aurora kinase inhibitor

CAS Number: 1094069-99-4
Compound CID: 25144732

Product Size

2 mg; 5 mg; 10 mg; 25 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

SCH-1473759 is an Aurora kinase inhibitor that disrupts cell division processes. It targets Aurora A and Aurora B.

Molecular Weight

426.54

Molecular Formula

C₂₀H₂₆N₈OS

Targets

Aurora A: 4 nM; Aurora B: 13 nM

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

SCH-1473759 can be used to analyze the effects of Aurora kinase inhibition in cancer models.

Storage

Store at -20ºC.